Company
Argenica Therapeutics Ltd
Headquarters: Nedlands, WA, Australia
Argenica Therapeutics Ltd Categories
Australia Healthcare BiotechnologyAustralia Healthcare Australia Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Argenica Therapeutics Limited researches and develops a neuroprotective therapeutic drug in Australia. The company's product is ARG-007, a neuroprotective peptide candidate for use in the protection of brain tissue against damage during a stroke and other acute central nervous system injuries. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Argenica Therapeutics Ltd has the following listings and related stock indices.
Stock: ASX: AGN wb_incandescent